Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Aureobasidin A, an antifungal antibiotic inhibiting a wide range of pathogenic fungi, is lethal for growing cells of susceptible fungi. We did cytological studies on the mechanism of its fungicidal action against Saccharomyces cerevisiae. When cultures were treated with 5.0 micrograms of aureobasidin A per ml, the numbers of viable cells started to decrease after 2 to 3 h of incubation, and most cells had lost viability after 5 to 6 h. When cell death in the treated cultures began, amino acids released by the cells could be detected, indicating disruption of the cell membrane. The proportion of cells with a single small bud or two or more buds increased as the population of viable cells decreased. Most such cells had the DNA content of cells in the G2 phase of the cell cycle, suggesting that the drug inhibited some cellular process involved in normal bud growth but did not affect DNA replication. Disruption of actin assembly was found in many cells treated for 2 to 3 h, as was chitin delocalization. The results suggest that aureobasidin A has a previously unknown mechanism of fungicidal action toward S. cerevisiae. It causes aberrant actin assembly, inhibiting the normal budding process and leading to cell death, probably through destruction of membrane integrity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties.
TAKESAKO, K., IKAI, K., HARUNA, F., ENDO, M., SHIMANAKA, K., SONO, E., NAKAMURA, T., KATO, I., & YAMAGUCHI, H. (1991) · The Journal of Antibiotics · doi:10.7164/antibiotics.44.919 · Cited by 149
Self-citation
Cited by
Antifungal activity and mode of action of silver nano-particles on Candida albicans
Kim, K.-J., Sung, W. S., Suh, B. K., Moon, S.-K., Choi, J.-S., Kim, J. G., & Lee, D. G. (2009) · BioMetals · doi:10.1007/s10534-008-9159-2 · Cited by 916
Antifungal Peptides: Novel Therapeutic Compounds against Emerging Pathogens
De Lucca, A. J., & Walsh, T. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.1 · Cited by 337
The molecular biology of fruity and floral aromas in beer and other alcoholic beverages
Holt, S., Miks, M. H., de Carvalho, B. T., Foulquié-Moreno, M. R., & Thevelein, J. M. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy041 · Cited by 296
Antifungal Peptides as Therapeutic Agents
Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 264
The current status of Aureobasidium pullulans in biotechnology
Prasongsuk, S., Lotrakul, P., Ali, I., Bankeeree, W., & Punnapayak, H. (2018) · Folia Microbiologica · doi:10.1007/s12223-017-0561-4 · Cited by 172
Metadata
- Authors
- Endo, M., Takesako, K., Kato, I., & Yamaguchi, H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1997-03
- Volume
- 41
- Issue
- 3
- Pages
- 672-676
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2099521932
- Cited by
- 106
- References
- 1
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.